Cellosaurus logo
expasy logo

Cellosaurus PD-1.3 (CVCL_DF55)

[Text version]
Cell line name PD-1.3
Synonyms PD1.3; PD1.3.1; PD1 3.1
Accession CVCL_DF55
Resource Identification Initiative To cite this cell line use: PD-1.3 (RRID:CVCL_DF55)
Comments Group: Patented cell line.
Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4122.
Monoclonal antibody isotype: IgG2b.
Monoclonal antibody target: UniProtKB; Q15116; Human PDCD1/PD1/CD279.
Species of origin Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Hierarchy Parent: CVCL_4032 (P3X63Ag8.653)
Category Hybridoma
Publications

PubMed=20587542; DOI=10.1093/intimm/dxq049
Ghiotto M., Gauthier L., Serriari N.-E., Pastor S., Truneh A., Nunes J.A., Olive D.
PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1.
Int. Immunol. 22:651-660(2010)

PubMed=20693422; DOI=10.4049/jimmunol.0902487
Serriari N.-E., Gondois-Rey F., Guillaume Y., Remmerswaal E.B.M., Pastor S., Messal N., Truneh A., Hirsch I., van Lier R.A.W., Olive D.
B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their function.
J. Immunol. 185:3140-3148(2010)

Patent=US9637546
Olive D., Serriari N.-E., Nunes J.A., Ghiotto M.
PD-1 antibodies and PD-L1 antibodies and uses thereof.
Patent number US9637546, 02-May-2017

Patent=US9896507
Olive D., Gondois-Rey F., Serriari N.-E., Pastor S.
BTLA antibodies and uses thereof.
Patent number US9896507, 20-Feb-2018

Patent=US10005839
Olive D., Pasero C., Gertner-Dardenne J.
Antagonist of the BTLA/HVEM interaction for use in therapy.
Patent number US10005839, 26-Jun-2018

Cross-references
Encyclopedic resources Wikidata; Q54946766
Entry history
Entry creation13-Jul-2016
Last entry update21-Mar-2023
Version number8